Market open
Conmed/$CNMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Conmed
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Ticker
$CNMD
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
3,900
ISIN
US2074101013
Website
Conmed Metrics
BasicAdvanced
$1.8B
15.38
$3.81
1.29
$0.80
1.36%
Price and volume
Market cap
$1.8B
Beta
1.29
52-week high
$78.58
52-week low
$46.00
Average daily volume
569K
Dividend rate
$0.80
Financial strength
Current ratio
2.257
Quick ratio
0.906
Long term debt to equity
91.184
Total debt to equity
98.387
Dividend payout ratio (TTM)
20.78%
Interest coverage (TTM)
4.43%
Management effectiveness
Return on assets (TTM)
4.14%
Return on equity (TTM)
12.96%
Valuation
Price to earnings (TTM)
15.381
Price to revenue (TTM)
1.376
Price to book
1.85
Price to tangible book (TTM)
-4.14
Price to free cash flow (TTM)
11.006
Dividend yield (TTM)
1.36%
Forward dividend yield
1.36%
Growth
Revenue change (TTM)
4.32%
Earnings per share change (TTM)
46.38%
3-year revenue growth (CAGR)
8.85%
3-year earnings per share growth (CAGR)
22.08%
What the Analysts think about Conmed
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Conmed stock.
Conmed Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Conmed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Conmed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Conmed stock?
Conmed (CNMD) has a market cap of $1.8B as of May 15, 2025.
What is the P/E ratio for Conmed stock?
The price to earnings (P/E) ratio for Conmed (CNMD) stock is 15.38 as of May 15, 2025.
Does Conmed stock pay dividends?
Yes, the Conmed (CNMD) stock pays dividends to shareholders. As of May 15, 2025, the dividend rate is $0.8 and the yield is 1.36%. Conmed has a payout ratio of 20.78% on a trailing twelve-month basis.
When is the next Conmed dividend payment date?
The next Conmed (CNMD) dividend payment date is unconfirmed.
What is the beta indicator for Conmed?
Conmed (CNMD) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.